JP2023506005A5 - - Google Patents

Info

Publication number
JP2023506005A5
JP2023506005A5 JP2022535688A JP2022535688A JP2023506005A5 JP 2023506005 A5 JP2023506005 A5 JP 2023506005A5 JP 2022535688 A JP2022535688 A JP 2022535688A JP 2022535688 A JP2022535688 A JP 2022535688A JP 2023506005 A5 JP2023506005 A5 JP 2023506005A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
prodrug
solvate
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022535688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506005A (ja
JP7644991B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/064583 external-priority patent/WO2021119475A1/en
Publication of JP2023506005A publication Critical patent/JP2023506005A/ja
Publication of JP2023506005A5 publication Critical patent/JP2023506005A5/ja
Application granted granted Critical
Publication of JP7644991B2 publication Critical patent/JP7644991B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022535688A 2019-12-13 2020-12-11 シスチン尿症のためのシスチンジアミド類似体 Active JP7644991B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962947799P 2019-12-13 2019-12-13
US62/947,799 2019-12-13
PCT/US2020/064583 WO2021119475A1 (en) 2019-12-13 2020-12-11 Cystine diamide analogs for cystinuria

Publications (3)

Publication Number Publication Date
JP2023506005A JP2023506005A (ja) 2023-02-14
JP2023506005A5 true JP2023506005A5 (enExample) 2023-12-18
JP7644991B2 JP7644991B2 (ja) 2025-03-13

Family

ID=76330597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022535688A Active JP7644991B2 (ja) 2019-12-13 2020-12-11 シスチン尿症のためのシスチンジアミド類似体

Country Status (11)

Country Link
US (1) US12486241B2 (enExample)
EP (1) EP4072537A4 (enExample)
JP (1) JP7644991B2 (enExample)
KR (1) KR20220115601A (enExample)
CN (1) CN115103669A (enExample)
AU (1) AU2020401565A1 (enExample)
BR (1) BR112022011572A2 (enExample)
CA (1) CA3161542A1 (enExample)
IL (1) IL293844A (enExample)
MX (1) MX2022007190A (enExample)
WO (1) WO2021119475A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9428453B2 (en) 2013-01-02 2016-08-30 Rutgers, The State University Of New Jersey Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
BR112022011572A2 (pt) 2019-12-13 2022-10-04 Univ Rutgers Análogos de cistina diamida para cistinúria
US20240150306A1 (en) * 2022-09-27 2024-05-09 Reinvigoron Theratech, Inc. Compounds with cleavable disulfide moieties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321306A1 (de) 1993-06-26 1995-01-05 Sanol Arznei Schwarz Gmbh Disulfide
US5801175A (en) 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6034135A (en) 1997-03-06 2000-03-07 Promega Biosciences, Inc. Dimeric cationic lipids
WO2003106636A2 (en) 2002-06-14 2003-12-24 Mirus Corporation Novel methods for the delivery of polynucleotides to cells
DE102005054700B4 (de) 2005-11-16 2009-01-08 Imtm Gmbh Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen
US9428453B2 (en) 2013-01-02 2016-08-30 Rutgers, The State University Of New Jersey Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
BR112022011572A2 (pt) 2019-12-13 2022-10-04 Univ Rutgers Análogos de cistina diamida para cistinúria

Similar Documents

Publication Publication Date Title
JP2023506005A5 (enExample)
JP2020531531A5 (enExample)
JP2024518554A5 (enExample)
JP2005523922A5 (enExample)
RU2010101611A (ru) Полициклические производные гуанина и способы их применения
JP2020531526A5 (enExample)
JP2022525069A5 (enExample)
RU2021139070A (ru) Ингибиторы ERBB/BTK
JP2017114876A5 (enExample)
JP2005514398A5 (enExample)
RU2014140739A (ru) Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения
JP2023504542A5 (enExample)
JP2020534336A5 (enExample)
JP2013523897A5 (enExample)
JP2009536221A5 (enExample)
JP2010280669A5 (enExample)
JP2017508816A5 (enExample)
JP2022141692A5 (enExample)
JP2007508362A5 (enExample)
JP2022505268A5 (enExample)
JP2013515037A5 (enExample)
JP2021528421A5 (enExample)
AR041855A1 (es) 4 amino-1- (piridilmetil) piperidina sustituida y compuestos relacionados
JP2012519703A5 (enExample)
JP2025160251A5 (enExample)